Scientists have found a way to combat respiratory failure after COVID-19

The research results are published in the EXCLI Journal.

It is noted that xenon affects the lung surfactant, a substance that prevents the collapse of the alveoli of the lungs.

Xenon atoms restore the affected sufactant, ensuring the expansion of the collapsed alveoli.

On November 23, Russian Health Minister Mikhail Murashko said that the shipment of an intravenous drug for the treatment of patients with coronavirus infection COVID-19 in hospitals is planned before the end of the week.